Related Experiment Video
Updated: Feb 1, 2026

Lipidico Injection Protocol for Serial Crystallography Measurements at the Australian Synchrotron
Published on: September 23, 2020
Why Most Australians Consider It Valuable to Find Harmless Abnormalities with Diagnostic Tests: A Mixed-Methods Study
Tomas Rozbroj1, Ming Hui Hoo1, Alexandra Gorelik1
1School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Many Australians seek diagnostic tests even when told they are unbeneficial. This is driven by beliefs in reassurance, biodata value, and skepticism that abnormalities are truly harmless, influencing patient testing choices.
Area of Science:
- Medical Decision Making
- Health Psychology
- Diagnostic Testing
Background:
- Individuals often desire diagnostic testing despite awareness of clinical non-benefit and risks.
- Patient preferences for testing are influenced by beliefs in the inherent value of any information obtained.
- Understanding these preferences is crucial for effective patient counseling and resource allocation.
Purpose of the Study:
- To investigate Australian adults' attitudes towards identifying harmless abnormalities via diagnostic tests.
- To explore the underlying beliefs associated with these attitudes.
- To identify factors influencing the demand for clinically unbeneficial diagnostic testing.
Main Methods:
- A mixed-methods approach combining survey data analysis.
- Qualitative analysis of free-text responses regarding attitudes to harmless abnormalities.
- Regression analysis to associate attitudes with broader beliefs and demographics.
Main Results:
- Nearly 60% of participants found value in identifying harmless abnormalities.
- Key drivers included perceived psychological reassurance, biodata acquisition, and monitoring potential.
- Skepticism about abnormalities being truly harmless and a belief in the broad utility of testing were significant underlying factors.
Conclusions:
- Patient choices for diagnostic tests are profoundly influenced by broader beliefs and psychological factors, not just clinical utility.
- Existing strategies to communicate test risks may be limited by failing to address these deeper beliefs.
- Future communication should address psychological drivers and broader beliefs to improve patient understanding and decision-making regarding diagnostic tests.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Pericarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests

